PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34361644-0	2021	Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-beta1 Signaling Pathway.	Fedratinib	0-10	signal transducer and activator of transcription 3	Homo sapiens	72-77	
26252788-8	2015	Fedratinib treatment led to reduced STAT3 phosphorylation but no meaningful change in JAK2V617F allele burden.	Fedratinib	0-10	signal transducer and activator of transcription 3	Homo sapiens	36-41	
24165976-7	2014	The relationship between fedratinib exposure and suppression of STAT3 phosphorylation was described using an inhibitory effect sigmoid Emax model, with an EC50 of 1,210 ng/mL in healthy subjects.	Fedratinib	25-35	signal transducer and activator of transcription 3	Homo sapiens	64-69	
33356802-11	2021	Fedratinib, a JAK/STAT inhibitor was evaluated and 78% tumor efficacy response was achieved.	Fedratinib	0-10	signal transducer and activator of transcription 3	Homo sapiens	18-22	
25572535-4	2015	Using the pharmaceutical inhibitor TG101348 or knockdown of STAT3 reduced the number of Th17 cells while promoting the number and function of Treg cells via the Janus kinase2 (JAK2)/STAT3 pathway in ACS patients.	Fedratinib	35-43	signal transducer and activator of transcription 3	Homo sapiens	182-187